These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3384939

  • 21. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH, Leonhard B.
    Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG, Wittenberger R.
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO, Gezelius L.
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [Abstract] [Full Text] [Related]

  • 25. Beta-lactamase inhibitors and Acinetobacter spp.
    Eng RH, Smith SM, Cherubin CE.
    J Antimicrob Chemother; 1990 Sep; 26(3):449-51. PubMed ID: 2172200
    [No Abstract] [Full Text] [Related]

  • 26. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
    Heizmann W, Heilmann F, Werner H.
    Infection; 1987 Sep; 15(5):370-4. PubMed ID: 3692611
    [Abstract] [Full Text] [Related]

  • 27. In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
    Fuchs PC, Barry AL, Thornsberry C, Gavan TL, Jones RN.
    Antimicrob Agents Chemother; 1983 Jul; 24(1):31-8. PubMed ID: 6625554
    [Abstract] [Full Text] [Related]

  • 28. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M, Stucki ZN, Torbert DP, Olweny J.
    J Am Osteopath Assoc; 2005 Jan; 105(1):25-6. PubMed ID: 15710671
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H, Heizmann W, Heilmann F.
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [Abstract] [Full Text] [Related]

  • 35. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 36. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 37. [In vitro activity of the amoxicillin-clavulanic acid combination on anaerobic bacteria. Comparison with amoxicillin, lamoxactam and metronidazole].
    Deforges L, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):540-3. PubMed ID: 6462743
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sulbactam and clavulanic acid: studies of enzyme kinetics and synergy with ampicillin and mezlocillin.
    Cullmann W, Stieglitz M, Opferkuch W.
    Drugs; 1988 Jun; 35 Suppl 7():71-6. PubMed ID: 3220009
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.